Hybrid closed-loop insulin therapy improves postpartum time in range

Share
Hybrid closed-loop insulin therapy improves postpartum time in range

New study co-authored by our Jaeb Center for Health Research members reveals the advantages of hybrid closed-loop (HCL) insulin therapy for postpartum women with type 1 diabetes! Study finds HCL users had 70% time in range postpartum—far higher than standard insulin therapy. lnkd.in/gmmpaRKR

Read the full article

Back to News
Share